DongKoo Bio & Pharma Co Ltd - ESG Rating & Company Profile powered by AI
The analysis of DongKoo Bio & Pharma Co Ltd is assembled by All Street Sevva using proprietary NLP. This article contains a Q&A table about DongKoo Bio & Pharma Co Ltd. Comprehensive Sustainability assessment of DongKoo Bio & Pharma Co Ltd can be accessed by signing up for free.
DongKoo Bio & Pharma Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | DongKoo Bio & Pharma Co Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does DongKoo Bio & Pharma Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd offer flexible work?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose water use targets?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid DongKoo Bio & Pharma Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas DongKoo Bio & Pharma Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs DongKoo Bio & Pharma Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose its waste policy?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose energy use targets?
Sign up for free to unlockDoes DongKoo Bio & Pharma Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes DongKoo Bio & Pharma Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for DongKoo Bio & Pharma Co Ltd
These potential risks are based on the size, segment and geographies of the company.
DongKoo Bio&Pharma. Co., Ltd. engages in the research, development, manufacture, and sale of medicines in South Korea. The company offers prescribed medicines, such as digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, nootropics and neurotonics, H+ pump inhibitors, antihistamines and antiallergics, and decongestants and nasal sprays, as well as non-selective a, ß-blockers. It also provides non-medical products, medical apparatus, and other cosmetic products, as well as household items and health functional foods. In addition, the company offers contract manufacturing services for OEMs and ODMs in the areas of prescribed medicine, general medicine, health foods, general foods, and quasi-authorized drugs in the form of soft gelatin capsules, hard capsules, tablets, powders, granules, externals, and liquids. DongKoo Bio&Pharma. Co., Ltd. has a partnership with Cerbios-pharma for the development of Cenilton for prostate treatment; and Ventrux for active probiotic intestinal treatment, as well as has a partnership with Lion Pharmaceutical company for the development of Dentheth ointment for the treatment of gum disease. The company exports its products to Vietnam, New Zealand, Thailand, Hong Kong, and Singapore. DongKoo Bio&Pharma. Co., Ltd. was founded in 1970 and is based in Seoul, South Korea.